Search

everythinglearnresearchcommunity

for

Search:↓

Stress can worsen skin conditions by affecting hormone levels and immune response.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Minoxidil doesn't increase pericardial disorder risk, but may cause fluid accumulation.

Understanding the genetics of rare inherited ichthyosis syndromes is key for better treatments and genetic counseling.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Smoking harms skin health, causing slower wound healing, more wrinkles, and worsening some skin conditions, but may protect against certain others.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Early treatment of superficial fungal infections in immunocompromised patients is crucial.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

DHT stops hair regrowth in mice, similar to human hair loss.

People with myotonic dystrophy type 1 have a higher chance of getting skin tumors, including melanoma.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.